New funding will help enterprises maximize AI profitability and create a unified standard for cloud business efficiency

BOSTON, May 28, 2025 — CloudZero, the globally trusted leader in proactive cloud cost efficiency, today announced a $56 million Series C funding round following another year of triple-digit growth. The funding will accelerate the company’s mission to power efficient innovation for cloud-driven organizations. The round was led by BlueCrest Capital Management and Innovius Capital, with participation from Matrix Partners, Threshold Ventures, Underscore VC, and G20 Ventures. MongoDB also made a strategic investment.

The funding will fuel AI-driven research and development, expand CloudZero’s go-to-market efforts, and strengthen its partner ecosystem.

With cloud spending projected to reach $2 trillion by 2030 and AI workloads reshaping infrastructure needs, CloudZero helps enterprises scale efficiently, improve unit economics, and stay ahead of the curve.

“Organizations that optimize their cloud costs gain a competitive advantage, while those that neglect cost management risk limiting their growth and innovation,” said Michael Platt, founder and CEO of BlueCrest Capital Management. “CloudZero gives customers financial control and predictability in the cloud — helping them boost profit, eliminate surprises, and reinvest in the next wave of innovation in critical areas like AI.”

CloudZero helps modern engineering teams understand, control, and optimize their cloud and AI infrastructure costs — connecting cloud decisions directly to business outcomes.

“AI is redefining what’s possible — but without a deep understanding of cloud unit economics, innovation becomes unsustainable,” said Phil Pergola, CEO of CloudZero. “CloudZero is pioneering a new standard for cloud cost optimization, giving companies the precision they need to scale cloud and AI responsibly.”

Already trusted by many of the world’s largest organizations — like Coinbase, DraftKings, Expedia, Moody’s, and Nubank — CloudZero will use its Series C funding to accelerate:

• AI-driven cost analytics and forecasting
• Deeper integrations across developer and finance workflows
• Expansion of strategic partners and cloud alliances

“This was a perfect time to partner with CloudZero,” said Benjamin Cefalo, senior vice president of product management at MongoDB. “The future of FinOps goes far beyond simple cost-cutting — it’s about cloud business efficiency. CloudZero is the only player in the market that truly understands this and is actively innovating toward that broader vision.”

About CloudZero

CloudZero is the leader in proactive cloud cost efficiency. We enable engineers to build cost-efficient software without slowing down innovation. CloudZero’s next-generation cloud cost optimization platform automates the collection, allocation, and analysis of cloud costs to uncover savings opportunities and improve unit economics. We are the only platform that enables companies to understand 100% of their operational cloud spend and take an engineering-led approach to optimizing that spend. CloudZero is used by industry leaders worldwide, such as Coinbase, Klaviyo, Miro, Nubank, and Rapid7. Visit cloudzero.com to get started today.

SOURCE CloudZero

MIAMI, May 27, 2025 — Portal Access, Inc., a medical device start-up company pioneering next-generation advanced vascular access solutions for oncology, announced the successful closing of a $7 million Series A financing round today. The round was fully subscribed, reflecting strong investor support for the company’s vision and technology. Over 80% of the round was led by U.S physician investors including oncologists, interventional radiologists, cardiologists, vascular surgeons and others, in addition to a partnership from a U.S based venture capital fund; underscoring strong clinical conviction and belief in the device’s potential to modernize cancer care drug delivery.

The funds will support regulatory activities and the planned 510(k) submission for approval to the U.S. Food and Drug Administration (FDA) for Flexi-Port^™ SLF-TANL^™, a novel subcutaneous port designed to simplify vascular access for oncology patients and a limited market launch. 510(k) submission is expected July 2025 and U.S market launch is anticipated in early 2026. The device is intended to enhance usability, reduce complexity, broaden accessibility and decrease costs.

Dr. Michael Tal, Founder and CEO of PorTal Access Inc. says “Closing this funding round represents an important milestone as we work toward regulatory approval. Flexi-Port^™ SLF-TANL^™ is engineered with a focus on simplicity, stability, and scalability — likely to support more efficient workflows in oncology access settings. It’s a solution for both clinicians and patients and created with the most optimal patient outcome and experience in mind.”

Despite being the standard of care, it is estimated that nearly half of cancer patients do not receive a chemo-port due to various reasons like delay in treatment. By simplifying access and potentially enabling placement in additional care settings, The Flexi-Port^™ SLF-TANL^™ device may help reduce treatment delays, procedural risks, and overall healthcare costs — improving the patient experience and operational efficiency across cancer care delivery.

“I have used the Flexi-Port SLF-TANL to provide chemotherapy in some of the most vulnerable patients and it has consistently exceeded expectations,” says Matthew Ostroff, RN, MSN, AGACNP, VABC, a pioneer in the field of bedside vascular access. “Its innovative self-tunneling technology is a revolutionary advancement offering a less invasive option that can be placed safely at the bedside or in an outpatient setting. From a clinical perspective, this technology has the potential to transform the standard of care in port placement – offering patients a more dignified, convenient, and compassionate experience at a time when it matters most.”

Angela Dotson, Executive VP of Business Development at PorTal Access, Inc. said, “In my career, I have never witnessed this level of enthusiasm from physicians for a medical technology. During our Series A round, the demand for the Flexi-Port^™ SLF-TANL^™ was overwhelming—$6 million of our funding came directly from individual physician investors. This type of physician-driven investment is both remarkable and virtually unprecedented. From a market development perspective, the response has been equally compelling. We are seeing significant interest from clinics and hospitals across the country, many of which are already preparing to integrate the Flexi-Port^™ SLF-TANL^™ into their practice as soon as it becomes available. They’ve been waiting more than 30 years for an innovation like this. Today, we are one step closer to delivering this transformative solution to clinicians and their patients.”

About PorTal Access, Inc.:
PorTal Access, Inc. is committed to designing solutions that aim to reduce complications currently associated with chemo port placement while offering a safe and minimally invasive option for bedside or in an outpatient setting. Flexi-Port^™ SLF-TANL^™ is currently not available for sale.

For more information or to be added to our market launch, please contact:
Angela Dotson
Executive VP Business Development
540-817-5515
[email protected]

SOURCE PorTal Access, Inc.

Pioneering collaboration marks a major step toward a smarter, faster, and more sustainable AI-enabled construction industry

REDWOOD CITY, Calif., May 27, 2025 — Neuron Factory, a Silicon Valley-based AI startup dedicated to revolutionizing the construction industry through cutting-edge AI software, announced its seed funding round and a strategic partnership with Cordeel Group, one of Europe’s premier one-stop partners for the complete construction process.

Neuron Factory’s AI coworker platform is powered by a proprietary enterprise task graph—a dynamic system that maps tasks, roles, and knowledge across an organization. This enables AI agents to operate intelligently within complex construction environments, supporting real-time coordination, task delegation, and decision-making. In an industry that relies on a complex web of discrete legacy tools, the company believes that agentic AI coworkers that orchestrate context-specific agents and allow teams at work to focus on their areas of expertise will improve efficiency throughout every phase of the construction process.

Neuron Factory was founded by a seasoned team of technology leaders: Zaid Kahn, formerly Vice President of Engineering at Microsoft; Salil Pandit, former Chief Product & Technology Officer at PrimaryBid and Engineering Lead at Waymo; and Tom De Raedt, founder of Escher Cloud. Their combined expertise spans AI systems, model training, and datacenter infrastructure—now focused on revolutionizing enterprise work in construction.

The company also announced $6 million in seed funding in an over-subscribed round, from Activant Capital, Colle Capital, Karman Ventures, Punch Capital and strategic investors including Filip Cordeel, Chairman of Cordeel Group.

“Construction stands as one of the largest and most intricate global industries—yet it remains largely untouched by the transformative power of real AI,” said Zaid Kahn, CEO and co-founder of Neuron Factory. “We’re proud to partner with Cordeel Group, a company that shares our belief in the transformative power of AI. Cordeel’s leadership and vision are helping shape the future of construction, and we’re excited to support their journey with our AI coworker platform.”

As the first construction company to pilot Neuron Factory’s AI coworker platform, Cordeel is reinforcing its commitment to delivering faster project timelines, higher returns for customers, and a more sustainable construction environment. The AI platform, designed to integrate seamlessly with existing construction workflows, will help Cordeel accelerate project execution, optimize resource use, and lay the groundwork for a new era of data-driven, transparent construction.

“At Cordeel Group, innovation is not just a strategy—it’s a catalyst for meaningful change and a reflection of our deeper purpose to build a more sustainable world for people and planet,” said Pascale Van Damme, CEO of Cordeel Group. “This partnership is a powerful step forward in our mission to transform the construction industry into a connected, intelligent, and regenerative ecosystem. By embracing AI, we’re not just enhancing our operations—we’re empowering our people, strengthening collaboration across the value chain, and creating the data foundation for transparent, traceable building passports that serve the EU’s climate goals. Together with Neuron Factory, we are shaping a future where innovation serves society, and where progress is measured not only in efficiency, but in the lasting value we create for generations to come.”

“At Cordeel, we have always believed in the power of innovation to drive human progress,” said Filip Cordeel. “This partnership with Neuron Factory is a testament to our commitment to leveraging cutting-edge technology to create a more efficient, sustainable, and future-proof construction industry. We are honored to lead this groundbreaking transformation, driven by a vision that will not only elevate our projects but also inspire lasting, positive change for our industry and our planet.”

“We believe that Neuron Factory isn’t just building another enterprise tool, they’re creating a new way for people and AI to work together,” said Victoria Grace, founding partner at Colle Capital. “Their approach to embedding agentic intelligence through a task graph and orchestration—where AI agents don’t just assist but autonomously learn, adapt, and collaborate—is exactly what the future of labor requires.”

About Neuron Factory

Founded in February 2025, Neuron Factory, Inc. is building the future of enterprise work through intelligent AI coworkers. Neuron Factory’s platform leverages a proprietary skills graph to orchestrate task execution and decision-making with AI agents through a unique user experience. The company is headquartered in Redwood City, CA.

Learn more at https://www.neuronfactory.ai/ or visit us on LinkedIn and X.

SOURCE Neuron Factory

Strategic investments highlight the company’s growth beyond design and development

RALEIGH, N.C., May 27, 2025 — Hyperspace Ventures has expanded its investment portfolio by deploying $6.8M since Q4 of 2024, focusing on both emerging tech and the fast-growing sport of pickleball.

“At our core, Hyperspace is a software design and development company,” said Taylor Meyer, Managing Partner. “We build, launch, and scale digital products. Recently, we’ve begun investing in high-growth companies we work with and have strong conviction in, as another mechanism to support our founders and accelerate their growth.”

This new initiative is conducted alongside a network of leading investors and advisors. Hyperspace deal flow is accessible to all accredited investors, offering a new opportunity for individuals to gain exposure to high-growth private companies and support the entrepreneurial ecosystem.

Hyperspace’s $6.8M Investment Breakdown:

• $515K into Ethos (formerly Learn to Win), enterprise performance & training platform;
• $670K into Bezel, marketplace for authenticated luxury watches;
• $50K into PinPrint, groundbreaking medical tech startup;
• $5.56M into pickleball-related ventures including tech, facilities, and pro pickleball

Hyperspace’s emphasis on pickleball positions the company as a key player in a sport that continues to surge in popularity, with a 223% participation growth in the U.S. over the last three years according to data from Pickleheads. The pickleball market was valued at over $1.5B in 2023.

“The $6.8 million deployed over the past nine months through Hyperspace’s investment initiative is just the beginning,” said Peter Fox, Managing Partner. “We’re proud to be building alongside founders shaping the next generation of innovation in the Raleigh-Durham area and beyond.”

About Hyperspace Ventures

Hyperspace Ventures is a North Carolina-based technology company that designs, builds, and invests in digital products for startups and leading brands. Specializing in web and mobile applications and cloud systems, Hyperspace has launched successful companies across diverse sectors.

Hyperspace has also created a suite of internal tools to support companies in operating efficiency, raising capital, talent acquisition, and networking. These tools include: Space Dial, Launch Deck, HyperHire, and The 42 Club.

For more information, visit hyperspaceventures.com.

To access Hyperspace’s deal flow, visit hyperspaceventures.com/investorsurvey

Media Contact: [email protected]

SOURCE Hyperspace Ventures

BANGALORE, India, May 27, 2025 — Frinks AI, a deep-tech startup founded by IIT Hyderabad alumni, has raised $5.4 million in a Pre-Series A round led by Prime Venture Partners, bringing its total funding to $6.25 million. The company is building next-generation Vision AI systems that help manufacturers automate and elevate quality control on their production lines.

The round also saw participation from existing investor Chiratae Ventures, along with Navam Capital and Ashok Atluri, Founder of Zen Technologies. Frinks AI is additionally backed by prominent industry leaders including Mr. S Ramadorai (former MD & CEO, TCS), Dr. V Sumantran (former Executive Director, Tata Motors), Dr. Tarun Ramadorai (Prof Imperial College of London), and Dr. Gopichand Katragadda (former Group CTO, Tata Sons), who continue to support the company as strategic investors and advisors.

What began as an ambitious idea in the research labs of IIT Hyderabad is now a transformative force in industrial AI. Founded by Aditya Agrawal, Dharmgya Sharma, and Subhra S. Bhattacherjee, Frinks AI is developing foundational vision models — highly generalizable AI systems purpose-built for visual inspection and quality control in manufacturing.

“With ongoing supply chain disruptions and rising global trade tensions, we’re seeing a strong push toward localized manufacturing as countries prioritize internal consumption,” said Aditya Agrawal, CEO and Co-founder of Frinks AI. “This marks the beginning of a new industrial revolution—one powered by advanced technologies that drive higher productivity and cost efficiency. Frinks AI is at the forefront of this transformation, helping manufacturers worldwide become more competitive, resilient, and future-ready.“

Frinks AI’s Vision AI platform is already in use by leading manufacturers across automobile, consumer goods, building materials, and medical devices sectors. Customers have reported measurable improvements in product quality, fewer defects, and major efficiency gains on the factory floor.

With the latest funding, Frinks AI aims to scale its platform across global markets, invest aggressively in R&D, and expand its presence in the US which is a key market for such technologies. To accelerate growth, the company is actively exploring partnerships with automation companies and OEM’s for a joint go-to-market initiative. These foundational models are designed to overcome long-standing reliability and generalisation challenges in industrial machine vision, by offering superior intelligence and greater adaptability.

“Visual inspection in manufacturing has been around for 50 years but owing to rule-based approach, its applicability has been limited to <15% scenarios typical on the assembly line. Frinks has leveraged advancements in image processing, AI compute to develop manufacturing specific machine vision models. By combining foundational models with in-house fine-tuning using a small set of images, Frinks is able to guarantee 99.99% accuracy to its customers. It is our pleasure to partner with Aditya, Dharmagya and Subhra in expanding this 10x product to India as well as taking it global,” said Brij Bhushan, Partner at Prime VP.

As factories embrace AI-led production, Frinks AI is enabling them to achieve higher quality, lower costs, and faster turnaround. Powered by five years of deep research, its foundational vision models automate the cognitive layer of manufacturing, starting with visual inspection and quality control.

With a no-code platform, manufacturers can easily customize workflows, integrate with existing systems, and scale across lines. Today, Frinks AI’s intelligence runs on over 1,000 production lines globally across automotive, consumer goods, medical devices, cement, and steel boosting throughput, reducing defects, and ensuring consistent quality.

Photo: https://mma.prnewswire.com/media/2696751/FRINKS_AI_Founders.jpg

SOURCE Frinks AI

NATICK, Mass., May 27, 2025 — Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced they have finalized $34.5M in funding, including a strategic investment from Illumina, structured financing from Soleus Capital and investments from existing investors.

Proceeds from this financing will be leveraged to advance Pillar’s commercial activities including headcount and infrastructure to support biopharma partnerships and expand adoption of its distributable clinical testing kits.

“We are very pleased with our commercial growth over the past few years,” said Gang Song, Founder and Executive Chairman of Pillar Biosciences. “We look forward to using this latest capital infusion to drive additional top-line growth as we move closer towards profitability.”

The financial investment by Illumina further reinforces its strong partnership with Pillar which includes previous agreements announced in 2017 and 2023.

“Pillar Biosciences has become an important strategic partner to enable Illumina to provide an expanded menu of research and clinical NGS solutions, accelerating access to precision oncology,” ” said Ashley Van Zeeland, vice president of Corporate Development Illumina. “Pillar’s rapid NGS targeted sequencing panels alongside Illumina’s state-of-the-art sequencing and bioinformatics solutions delivers rapid, cost-effective genomic profiling of tumors, which is critical to advancing personalized therapy globally.”

“Access to rapid NGS testing solutions is critical to advancing precision medicine in oncology.  We see Pillar’s technology as a market leader, helping laboratories across the globe more effectively streamline and consolidate their molecular testing platforms, enabling faster time to results,” said Benjamin Lund from Soleus Capital. “Pillar has demonstrated strong commercial growth over the past few years, including multiple biopharma collaborations.”

About Pillar Biosciences

Pillar Biosciences is the leader in Decision Medicine™, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to generate data that optimizes selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring. Pillar’s NGS testing solutions are powered by its proprietary SLIMamp® and PiVAT® technologies, helping to localize the testing process, reduce diagnostic costs and improve access and efficiency of complex NGS testing for clinicians, prescribers, and patients globally. The company has more than 20 NGS testing kits available in IVD or RUO formats, with multiple panels in various stages of development. Pillar Biosciences has operations in Natick, MA. For more information visit pillarbiosci.com and connect with us on LinkedIn.

SOURCE Pillar Biosciences, Inc.

Bito helps software engineering teams review code in 10,000+ pull requests each week and speed up their time-to-merge by 89%. Enterprises like Gainsight, Whatfix, and PubMatic ship daily with Bito’s AI code reviews. 

SAN FRANCISCO, May 27, 2025 — Bito, an AI developer platform transforming how developers review and improve code by deeply understanding their codebase, today announced a $5.7 million seed extension round, led by Vela Partners, with participation from NextView Ventures, Maxitech Ventures, Eniac Ventures and others. This brings the company’s total seed-stage funding to $8.8 million.

Bito is pioneering the shift to agentic AI software development for enterprises by focusing on one of the most critical and overlooked parts of the modern dev cycle: code review. Its flagship product, the AI Code Review Agent, integrates directly into GitHub, GitLab, and Bitbucket workflows to provide developers with line-by-line feedback, issue detection, performance optimizations, and one-click fix suggestions across over 50 programming languages. Its platform plans and reasons through code review, like how a human would. Bito deeply understands the code context and architectural design patterns of a codebase while maintaining enterprise-grade security. 

Each week, Bito reviews and improves more than 10,000 pull requests for enterprises like Gainsight, Whatfix, and PubMatic.

“Everyone talks about writing code with AI. But production systems live and die by how well that code is reviewed, tested, and maintained,” said Amar Goel, co-founder and CEO of Bito. “With this funding, we’ll deepen our technology’s dynamic insight and codebase awareness to help teams navigate the flood of AI-generated and human-written code that’s only just begun.”

Commonly used languages on the platform are JavaScript, Typescript, Python, and Java, with growing adoption in Go and C#. Teams that use Bito see 89% faster pull request merges, 34% fewer regressions, 87% of pull request feedback provided by AI, and $14 returns for every $1 spent on its tooling. 

“Dev velocity is increasing, but reviews can’t keep up. Quality slips as fewer engineers understand the whole codebase. Soon no engineers will have a handle. Bito’s AI-first code review infrastructure adapts the engineering teams to this rapidly changing world,” said Yigit Ihlamur of Vela Partners.

Bito’s funding will be used to expand its agentic tooling and AI Code Reviews, invest in deeper integrations with CI/CD systems, and grow its team across engineering, product, and go-to-market functions.

Media Contact

Alexander Tibbets

[email protected]

SOURCE Bito

After 5 consecutive quarters of revenue growth, Bespoken is poised to attain profitability within the next year

LEXINGTON, Ky., May 27, 2025 — Bespoken Spirits, a pioneering innovator in sustainable, precision-aged spirits, is proud to announce the successful close of its Series-C funding round. The round, which culminates on May 30, underscores the market’s confidence in Bespoken’s revolutionary maturation technology, unprecedented speed to market for private labels large and small, and its bold vision for the future of the spirits industry.

Backed by more than 100 individual investors, Bespoken Spirits has raised over $11 million in Series-C. This new round of capital will accelerate the company’s efforts to expand its market presence, scale production capabilities, and further invest in its proprietary technology to bring world-class, new flavors and aromas to the world.

“We’re happy to successfully close our Series-C round,” said TJ Rodgers, Chairman of Bespoken Spirits’ Board of Directors. “It’s a clear validation of our mission to disrupt and modernize the spirits industry while promoting sustainability, efficiency, and unmatched product quality innovation. With the continued support of our investors, we’re well-positioned to drive the next phase of growth and achieve cashflow breakeven.”

Bespoken Spirits has already made headlines for winning over 240 medals in prestigious tasting competitions in San Francisco, New York and Europe, enabled by the precise control of the spectrum of natural aging compounds. Its patented technology not only reduces the environmental footprint of spirit production but also empowers distillers with unprecedented precision of taste, aroma, and mouthfeel.

We thank our investors for their support and the myriad of benefits it will produce.

About Bespoken Spirits
Founded in Silicon Valley, Bespoken Spirits is a groundbreaking spirits company, revolutionizing the industry through its finishing process, using all-natural elements of wood, toast and char. Now located in Lexington, Kentucky, its experts have created over 5,000 unique whiskey trials, all using less wood, water and energy.

SOURCE Bespoken Spirits

• Backed by 20+ leading international corporations, Cathay Innovation has built the world’s largest VC platform that invests and connects emerging startups to real world industries including consumer, healthcare, financial services and energy
• Fund III marks the largest AI-dedicated venture capital fund out of the European Union investing globally in vertical AI
• To date the fund has made 14 investments across the U.S., Europe and Asia

PARIS, May 27, 2025 — Cathay Innovation today announced the final close of its latest venture capital fund at $1B, making it the largest AI-dedicated fund out of the European Union. While headquartered in France, the fund invests across Europe, the U.S., and Asia in vertical AI solutions in four key sectors: digital health, fintech, consumer and mobility / energy.

The successful close signals a greater shift in AI-era venture capital, where the success of startups and established industry players are increasingly intertwined. Fund III is backed by a diverse base of institutional investors as well as multinational corporations looking to access the latest AI startup technologies key to industry wide transformation. This includes major organizations such as Sanofi, TotalEnergies, Valeo, BNP Paribas Cardif, Groupe SEB and Groupe ADP (Paris Aéroport) since first closing, joined by several international industry players including Vale Ventures, Copec WIND Ventures and more.

“In one of the most challenging fundraising periods the venture industry has seen, Fund III illustrates the power of value-added capital,” said Mingpo Cai, Founder and Chairman of Cathay Capital and Cathay Innovation. “The benefits of the Cathay platform go far beyond capital, it’s rooted in providing solutions that are useful to our investors, corporate partners and founders. Regardless of macroeconomic uncertainties, the AI-driven transformation of industries will go on. Our mission is to support local champions and create ecosystem synergies that benefit all stakeholders while creating lasting economic and societal impact.”

Where AI Meets Industry: Largest Platform for Collaborative Transformation

Beyond investment, Cathay Innovation’s global platform connects startups with its corporate ecosystem, a broad network of 20+ Fortune 500 corporations to facilitate deeper industry collaboration. This includes strategic partnerships, co-investments or other business development opportunities such as global biopharma Sanofi’s ongoing AI initiatives with Cathay Innovation portfolio companies Owkin, AQEMIA or Inato. This not only helps startups scale earlier and faster, but it helps corporations access cutting-edge technologies at a time when transformation is mission critical.

“Fund III represents a new kind of VC fund built for the AI era, with the capital and ecosystem needed for real industrial and societal change,” said Denis Barrier, Co-founder of Cathay Innovation. “AI is a general-purpose technology—like electricity— not offering incremental improvements, but with the potential to reinvent entire industries. This shift has redefined the role of startups from disruptors to transformation partners, with collaboration now the new currency for success. Over the past decade, we’ve built the world’s largest venture capital platform that can connect startups and corporate innovation under one roof to drive this transformation together.”

Cathay Innovation Fund III: Purpose-built for the New Industrial Era

Fund III primarily focuses on startups applying AI deeply tailored to specific sectors. Focusing on Series A, B and late-stage startups, Fund III invests between $5 and $100 million, leading or co-leading rounds and reserving capital for follow-on support. To date, it has invested in 14 startups across the U.S., Europe and Asia including:

• Healthcare: Nabla (AI co-pilot for physicians), AQEMIA (AI + quantum physics drug discovery), Bioptimus (first universal foundation model for biology), Nelly (European fintech simplifying healthcare payments)
   
• Financial Services: Range (AI-driven wealth management), Flowdesk (full-stack market-making for digital assets), Ping++ (Open banking and payment infrastructure)
   
• Consumer: Ghost (B2B marketplace for excess inventory), Reebelo (marketplace for refurbished tech devices), Imagino (customer data platform for modern brands), Mogic (genAI-powered short-form video creation), Beatbot (intelligent robotic cleaning systems)
   
• Energy: David Energy (next-gen retail energy platform), Entalpic (foundation model-based materials discovery for low-carbon innovations)

The firm’s geographic diversity is a strategic advantage in today’s fragmented world, helping startups in the U.S., for example, operate successfully in Europe, Latam or other parts of the world and vice versa. Fund III is also classified as an Article 8 fund under the EU’s Sustainable Finance Disclosure Regulation (SFDR), reflecting its commitment to environmental and social impact. It backs high-growth companies where AI is used to advance industries in ways that are locally grounded, globally scalable and socially positive.

About Cathay Innovation

Cathay Innovation is a multistage venture capital firm, affiliated to Cathay Capital, investing in founders building transformative businesses across Europe, North America, Asia, Latin America and Africa. Its platform connects founders with investors and its ecosystem of leading Fortune500 corporations to help startups scale and transform industries with consumer to enterprise and AI solutions in commerce, fintech, digital health and mobility / energy. Founded in Paris in 2015, Cathay Innovation now manages over €2.5B AUM with additional offices in San Francisco, Berlin, Madrid, Shanghai and Singapore and has invested in over 120 startups including Chime, Pinduoduo, Glovo, Wallbox, Owkin, Getaround, Ledger, ZenBusiness, Alma, Descartes Underwriting and more. To learn more, visit us at www.cathayinnovation.com.

Media Contact:
Michael Celiceo, CodePR
[email protected]

SOURCE Cathay Innovation